Symbols / MDWD Stock $16.50 -3.40% MediWound Ltd.

Healthcare • Biotechnology • Israel • NGM
MDWD (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Stock Fundamentals
Scroll to Statements
Market Cap 212.06M Enterprise Value 175.04M Income -23.88M Sales 16.96M Book/sh 3.40 Cash/sh 4.14
Dividend Yield — Payout 0.00% Employees 121 IPO — P/E — Forward P/E -7.60
PEG — P/S 12.50 P/B 4.85 P/C — EV/EBITDA -7.21 EV/Sales 10.32
Quick Ratio 2.16 Current Ratio 2.33 Debt/Eq 20.11 LT Debt/Eq — EPS (ttm) -2.10 EPS next Y -2.17
EPS Growth — Revenue Growth -68.00% Earnings 2026-05-20 ROA -19.77% ROE -63.86% ROIC —
Gross Margin 19.19% Oper. Margin -4.18% Profit Margin -140.80% Shs Outstand 12.85M Shs Float 9.76M Short Float 13.86%
Short Ratio 19.21 Short Interest — 52W High 22.50 52W Low 14.90 Beta 0.15 Avg Volume 94.78K
Volume 19.19K Target Price $31.33 Recom Strong_buy Prev Close $17.08 Price $16.50 Change -3.40%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$31.33
Mean price target
2. Current target
$16.50
Latest analyst target
3. DCF / Fair value
$-21.82
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$16.50
Low
$25.00
High
$39.00
Mean
$31.33

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-11-21 main HC Wainwright & Co. Buy → Buy $36
2025-05-22 main HC Wainwright & Co. Buy → Buy $31
2025-03-20 reit HC Wainwright & Co. Buy → Buy $25
2025-02-28 init Craig-Hallum — → Buy $39
2025-01-10 reit HC Wainwright & Co. Buy → Buy $25
2024-11-27 main HC Wainwright & Co. Buy → Buy $25
2024-10-11 reit HC Wainwright & Co. Buy → Buy $28
2024-08-15 reit HC Wainwright & Co. Buy → Buy $28
2024-07-16 reit HC Wainwright & Co. Buy → Buy $28
2024-05-30 reit HC Wainwright & Co. Buy → Buy $28
2024-03-22 reit HC Wainwright & Co. Buy → Buy $28
2024-01-16 main HC Wainwright & Co. Buy → Buy $28
2023-11-22 reit HC Wainwright & Co. Buy → Buy $26
2023-09-21 main HC Wainwright & Co. Buy → Buy $26
2023-08-17 main Oppenheimer Outperform → Outperform $36
2023-08-17 reit HC Wainwright & Co. Buy → Buy $23
2023-05-31 reit Oppenheimer Outperform → Outperform $63
2023-05-31 reit HC Wainwright & Co. Buy → Buy $23
2023-03-17 reit HC Wainwright & Co. — → Buy $23
2023-01-04 main HC Wainwright & Co. — → Buy $23
News
RSS: Latest MDWD news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
16.96
-16.14%
20.22
+8.22%
18.69
-29.48%
26.50
Operating Revenue
16.96
-16.14%
20.22
+8.22%
18.69
-29.48%
26.50
Cost Of Revenue
13.71
-22.08%
17.59
+16.42%
15.11
+13.33%
13.33
Reconciled Cost Of Revenue
12.13
-25.71%
16.33
+16.33%
14.04
+13.84%
12.33
Gross Profit
3.25
+23.54%
2.63
-26.38%
3.58
-72.82%
13.16
Operating Expense
28.53
+29.60%
22.02
+15.39%
19.08
-8.39%
20.83
Research And Development
14.32
+61.30%
8.88
+18.90%
7.47
-26.66%
10.18
Selling General And Administration
13.93
+7.86%
12.91
+13.47%
11.38
+9.70%
10.37
Selling And Marketing Expense
3.87
+21.06%
3.20
+14.02%
2.80
+37.47%
2.04
General And Administrative Expense
10.06
+3.52%
9.71
+13.30%
8.57
+2.90%
8.33
Salaries And Wages
6.92
+5.44%
6.57
+19.14%
5.51
+10.66%
4.98
Other Gand A
3.13
-0.48%
3.15
+2.78%
3.06
-8.62%
3.35
Other Operating Expenses
—
—
—
0.68
Total Expenses
42.24
+6.65%
39.60
+15.85%
34.19
+0.09%
34.16
Operating Income
-25.28
-30.43%
-19.38
-25.04%
-15.50
-102.34%
-7.66
Total Operating Income As Reported
-25.27
-30.24%
-19.40
-26.88%
-15.29
-83.22%
-8.35
EBITDA
-21.47
+23.12%
-27.93
-481.71%
-4.80
+73.69%
-18.25
Normalized EBITDA
-22.21
-29.13%
-17.20
-35.78%
-12.67
-35.76%
-9.33
Reconciled Depreciation
1.86
+25.42%
1.48
+13.81%
1.30
+2.44%
1.27
EBIT
-23.33
+20.68%
-29.41
-381.83%
-6.10
+68.73%
-19.52
Total Unusual Items
0.74
+106.90%
-10.73
-236.37%
7.87
+188.21%
-8.92
Total Unusual Items Excluding Goodwill
0.74
+106.90%
-10.73
-236.37%
7.87
+188.21%
-8.92
Special Income Charges
—
—
0.21
—
Other Special Charges
—
—
-0.21
—
Net Income
-23.88
+20.99%
-30.22
-350.03%
-6.72
+65.73%
-19.60
Pretax Income
-23.71
+21.39%
-30.16
-361.84%
-6.53
+66.54%
-19.52
Net Non Operating Interest Income Expense
0.82
+2431.43%
-0.04
-103.17%
1.10
+148.85%
-2.26
Interest Expense Non Operating
0.38
-49.47%
0.75
+76.11%
0.43
0.00
Net Interest Income
0.82
+2431.43%
-0.04
-103.17%
1.10
+148.85%
-2.26
Interest Expense
0.38
-49.47%
0.75
+76.11%
0.43
0.00
Interest Income Non Operating
1.86
-9.23%
2.05
-12.52%
2.34
+767.04%
0.27
Interest Income
1.86
-9.23%
2.05
-12.52%
2.34
+767.04%
0.27
Other Income Expense
0.75
+107.01%
-10.75
-236.60%
7.87
+181.93%
-9.60
Other Non Operating Income Expenses
0.01
+172.22%
-0.02
—
-0.68
Gain On Sale Of Security
0.74
+106.90%
-10.73
-240.13%
7.66
+185.85%
-8.92
Tax Provision
0.17
+177.05%
0.06
-67.03%
0.18
+137.18%
0.08
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.16
+106.90%
-2.25
-236.37%
1.65
+188.21%
-1.87
Net Income Including Noncontrolling Interests
-23.88
+20.99%
-30.22
-350.03%
-6.72
+65.73%
-19.60
Net Income From Continuing Operation Net Minority Interest
-23.88
+20.99%
-30.22
-350.03%
-6.72
+65.73%
-19.60
Net Income From Continuing And Discontinued Operation
-23.88
+20.99%
-30.22
-350.03%
-6.72
+65.73%
-19.60
Net Income Continuous Operations
-23.88
+20.99%
-30.22
-350.03%
-6.72
+65.73%
-19.60
Net Income Discontinuous Operations
—
—
—
0.00
Normalized Income
-24.46
-12.48%
-21.75
-68.19%
-12.93
-3.00%
-12.55
Net Income Common Stockholders
-23.88
+20.99%
-30.22
-350.03%
-6.72
+65.73%
-19.60
Diluted EPS
-2.10
+30.69%
-3.03
-304.00%
-0.75
+80.92%
-3.93
Basic EPS
-2.10
+30.69%
-3.03
-304.00%
-0.75
+80.92%
-3.93
Basic Average Shares
11.38
+14.23%
9.96
+10.50%
9.01
+80.73%
4.99
Diluted Average Shares
11.38
+14.23%
9.96
+10.50%
9.01
+80.73%
4.99
Diluted NI Availto Com Stockholders
-23.88
+20.99%
-30.22
-350.03%
-6.72
+65.73%
-19.60
Depreciation Amortization Depletion Income Statement
0.29
+26.32%
0.23
-2.98%
0.23
-14.23%
0.27
Depreciation And Amortization In Income Statement
0.29
+26.32%
0.23
-2.98%
0.23
-14.23%
0.27
Total Other Finance Cost
0.66
-50.19%
1.33
+64.12%
0.81
-67.92%
2.53
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
86.25
+17.36%
73.50
+10.59%
66.46
+32.88%
50.02
Current Assets
59.96
+14.96%
52.16
+4.97%
49.70
+8.41%
45.84
Cash Cash Equivalents And Short Term Investments
53.14
+23.12%
43.16
+263.74%
11.87
-64.99%
33.90
Cash And Cash Equivalents
4.80
-47.58%
9.15
-22.85%
11.87
-64.99%
33.90
Cash Financial
4.80
-47.58%
9.15
-22.85%
11.87
-64.99%
33.90
Other Short Term Investments
48.34
+42.15%
34.01
+14.59%
29.68
0.00
Receivables
2.37
-59.47%
5.85
+32.43%
4.42
-54.42%
9.70
Accounts Receivable
1.62
-66.23%
4.80
+29.73%
3.70
-60.35%
9.33
Gross Accounts Receivable
1.73
-64.75%
4.92
+32.68%
3.71
-60.30%
9.33
Allowance For Doubtful Accounts Receivable
-0.11
+4.27%
-0.12
-1850.00%
-0.01
-200.00%
-0.00
Other Receivables
0.75
-28.61%
1.05
+46.31%
0.72
+98.07%
0.36
Inventory
4.09
+52.04%
2.69
-5.41%
2.85
+44.98%
1.96
Raw Materials
1.72
+19.25%
1.44
+45.13%
0.99
+8.98%
0.91
Finished Goods
2.37
+89.98%
1.25
-32.58%
1.85
+76.29%
1.05
Prepaid Assets
0.36
-21.62%
0.46
-36.57%
0.72
+151.57%
0.29
Restricted Cash
—
34.01
+13.95%
29.84
0.00
Total Non Current Assets
26.29
+23.24%
21.33
+27.25%
16.76
+301.44%
4.18
Net PPE
25.79
+24.03%
20.80
+30.57%
15.93
+344.74%
3.58
Gross PPE
35.21
+22.56%
28.73
+24.56%
23.06
+129.61%
10.04
Accumulated Depreciation
-9.41
-18.73%
-7.93
-11.13%
-7.14
-10.41%
-6.46
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
8.07
+13.34%
7.12
—
—
Machinery Furniture Equipment
23.16
+27.61%
18.15
+39.75%
12.99
+134.04%
5.55
Other Properties
—
—
6.70
+451.28%
1.22
Leases
3.97
+15.04%
3.45
+2.25%
3.38
+2.93%
3.28
Goodwill And Other Intangible Assets
0.03
-66.67%
0.10
-40.00%
0.17
-28.57%
0.23
Other Intangible Assets
0.03
-66.67%
0.10
-40.00%
0.17
-28.57%
0.23
Non Current Accounts Receivable
0.03
—
0.23
+29.44%
0.18
Other Non Current Assets
0.44
+0.00%
0.44
-0.23%
0.44
+139.13%
0.18
Total Liabilities Net Minority Interest
42.62
+0.66%
42.34
+21.45%
34.86
-10.84%
39.10
Current Liabilities
25.71
-3.14%
26.54
+46.43%
18.12
+50.33%
12.06
Payables And Accrued Expenses
11.00
+31.24%
8.38
-10.80%
9.39
-3.66%
9.75
Payables
3.91
-11.23%
4.41
-26.30%
5.98
-17.85%
7.28
Accounts Payable
3.61
-11.94%
4.10
-3.01%
4.22
-25.34%
5.66
Other Payable
0.22
-2.65%
0.23
-86.51%
1.68
+27.09%
1.32
Current Accrued Expenses
7.08
+78.37%
3.97
+16.34%
3.41
+38.16%
2.47
Employee Benefits
0.47
+16.83%
0.40
-11.40%
0.46
+26.67%
0.36
Pensionand Other Post Retirement Benefit Plans Current
—
—
—
0.42
Current Deferred Liabilities
1.18
+158.42%
0.46
+1804.17%
0.02
-61.90%
0.06
Current Deferred Revenue
1.18
+158.42%
0.46
+1804.17%
0.02
-61.90%
0.06
Other Current Liabilities
13.53
-23.58%
17.70
+103.35%
8.71
+288.31%
2.24
Total Non Current Liabilities Net Minority Interest
16.91
+7.04%
15.80
-5.60%
16.74
-38.11%
27.05
Long Term Debt And Capital Lease Obligation
8.15
+25.17%
6.51
+2.57%
6.35
+650.59%
0.85
Long Term Capital Lease Obligation
8.15
+25.17%
6.51
+2.57%
6.35
+650.59%
0.85
Non Current Pension And Other Postretirement Benefit Plans
0.47
+16.83%
0.40
-11.40%
0.46
+26.67%
0.36
Non Current Deferred Liabilities
0.00
-100.00%
0.74
0.00
0.00
Non Current Deferred Revenue
0.00
-100.00%
0.74
0.00
0.00
Other Non Current Liabilities
8.29
+1.74%
8.15
-17.96%
9.93
-2.93%
10.23
Stockholders Equity
43.63
+40.06%
31.15
-1.40%
31.59
+189.49%
10.91
Common Stock Equity
43.63
+40.06%
31.15
-1.40%
31.59
+189.49%
10.91
Capital Stock
0.26
+20.00%
0.21
+16.85%
0.18
+28.67%
0.14
Common Stock
0.26
+20.00%
0.21
+16.85%
0.18
+28.67%
0.14
Share Issued
12.84
+18.92%
10.79
+17.04%
9.22
+27.37%
7.24
Ordinary Shares Number
12.84
+18.92%
10.79
+17.04%
9.22
+27.37%
7.24
Additional Paid In Capital
272.33
+15.40%
236.00
+14.42%
206.25
+15.30%
178.88
Retained Earnings
-228.93
-11.65%
-205.05
-17.29%
-174.82
-4.00%
-168.11
Gains Losses Not Affecting Retained Earnings
-0.03
-190.91%
-0.01
+38.89%
-0.02
-260.00%
-0.01
Total Equity Gross Minority Interest
43.63
+40.06%
31.15
-1.40%
31.59
+189.49%
10.91
Total Capitalization
43.63
+40.06%
31.15
-1.40%
31.59
+189.49%
10.91
Working Capital
34.26
+33.70%
25.62
-18.84%
31.57
-6.55%
33.78
Invested Capital
43.63
+40.06%
31.15
-1.40%
31.59
+189.49%
10.91
Total Debt
8.15
+25.17%
6.51
+2.57%
6.35
+650.59%
0.85
Capital Lease Obligations
8.15
+25.17%
6.51
+2.57%
6.35
+650.59%
0.85
Net Tangible Assets
43.60
+40.40%
31.05
-1.20%
31.43
+194.21%
10.68
Tangible Book Value
43.60
+40.40%
31.05
-1.20%
31.43
+194.21%
10.68
Derivative Product Liabilities
—
—
7.30
-53.25%
15.61
Dueto Related Parties Current
0.09
+0.00%
0.09
+3.61%
0.08
-72.96%
0.31
Foreign Currency Translation Adjustments
-0.03
-190.91%
-0.01
+38.89%
-0.02
-260.00%
-0.01
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-16.12
-18.33%
-13.62
-30.19%
-10.46
+11.95%
-11.88
Cash Flow From Continuing Operating Activities
-16.12
-18.33%
-13.62
-30.19%
-10.46
+11.95%
-11.88
Cash From Discontinued Operating Activities
—
—
—
0.00
Net Income From Continuing Operations
-23.88
+20.99%
-30.22
-350.03%
-6.72
+65.73%
-19.60
Depreciation Amortization Depletion
1.86
+25.42%
1.48
+13.81%
1.30
+2.44%
1.27
Depreciation And Amortization
1.86
+25.42%
1.48
+13.81%
1.30
+2.44%
1.27
Other Non Cash Items
0.20
+1775.00%
-0.01
+99.07%
-1.29
-691.74%
0.22
Pension And Employee Benefit Expense
0.03
+203.33%
-0.03
-136.14%
0.08
-23.85%
0.11
Stock Based Compensation
3.11
-0.96%
3.14
+61.75%
1.94
-0.31%
1.95
Operating Gains Losses
-2.18
-120.32%
10.72
+233.38%
-8.04
-169.76%
11.52
Gain Loss On Investment Securities
-2.16
-120.16%
10.70
+228.81%
-8.31
-176.32%
10.89
Net Foreign Currency Exchange Gain Loss
-0.05
-208.51%
0.05
-75.13%
0.19
-64.00%
0.53
Change In Working Capital
4.77
+275.35%
1.27
-45.63%
2.34
+132.25%
-7.24
Change In Receivables
4.88
+577.57%
-1.02
-121.43%
4.76
+166.00%
-7.22
Changes In Account Receivables
3.21
+381.42%
-1.14
-120.17%
5.66
+174.62%
-7.58
Change In Inventory
-1.36
-828.88%
0.19
+120.64%
-0.91
-25.66%
-0.72
Change In Payables And Accrued Expense
1.25
+35.86%
0.92
+160.64%
-1.52
-318.99%
0.69
Change In Payable
1.25
+35.86%
0.92
+160.64%
-1.52
-318.99%
0.69
Change In Account Payable
2.35
+478.82%
0.41
+168.35%
-0.59
-243.48%
0.41
Change In Other Working Capital
—
1.18
—
—
Investing Cash Flow
-17.95
-113.77%
-8.40
+75.53%
-34.32
-7035.34%
-0.48
Cash Flow From Continuing Investing Activities
-17.95
-113.77%
-8.40
+75.53%
-34.32
-7035.34%
-0.48
Cash From Discontinued Investing Activities
—
—
—
—
Net PPE Purchase And Sale
-5.50
+12.24%
-6.27
+2.95%
-6.46
-1064.68%
-0.56
Purchase Of PPE
-5.50
+12.24%
-6.27
+2.95%
-6.46
-1064.68%
-0.56
Capital Expenditure
-5.50
+12.24%
-6.27
+2.95%
-6.46
-1064.68%
-0.56
Net Investment Purchase And Sale
-14.04
-220.75%
-4.38
+85.32%
-29.80
0.00
Sale Of Investment
—
—
—
0.00
Financing Cash Flow
29.62
+52.73%
19.39
-15.37%
22.92
-35.92%
35.76
Cash Flow From Continuing Financing Activities
29.62
+52.73%
19.39
-15.37%
22.92
-35.92%
35.76
Net Common Stock Issuance
27.42
+23.69%
22.16
-11.02%
24.91
-35.10%
38.38
Proceeds From Stock Option Exercised
3.63
+200.00%
1.21
0.00
-100.00%
0.01
Net Other Financing Charges
-1.43
+64.18%
-3.98
-99.85%
-1.99
+24.14%
-2.63
Changes In Cash
-4.45
-69.43%
-2.63
+87.99%
-21.87
-193.47%
23.40
Effect Of Exchange Rate Changes
0.10
+213.10%
-0.08
+47.50%
-0.16
+70.86%
-0.55
Beginning Cash Position
9.15
-22.85%
11.87
-64.99%
33.90
+206.85%
11.05
End Cash Position
4.80
-47.58%
9.15
-22.85%
11.87
-64.99%
33.90
Free Cash Flow
-21.63
-8.69%
-19.90
-17.53%
-16.93
-36.09%
-12.44
Common Stock Issuance
27.42
+23.69%
22.16
-11.02%
24.91
-35.10%
38.38
Interest Received CFI
1.59
-29.35%
2.25
+15.67%
1.95
+2531.08%
0.07
Issuance Of Capital Stock
27.42
+23.69%
22.16
-11.02%
24.91
-35.10%
38.38
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category